Want to see IN:OAL full AI Analyst Report?
Oriental Aromatics Ltd. (OAL) AI Stock Analysis
Top Page
Oriental Aromatics Ltd.
(NSE:OAL)
The score is held back primarily by weak financial quality—sharp margin compression, volatile earnings, recurring negative operating/free cash flow, and higher leverage. Technicals are a positive (strong uptrend and bullish momentum), but the stock appears stretched (high RSI). Valuation is a key risk: an extremely high P/E contrasts with pressured profitability, partially offset by a high dividend yield.
Oriental Aromatics Ltd. (OAL) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 19.16B
- Dividend Yield
- 0.09%
- Average Volume (3M)
- 6,841
- Price to Earnings (P/E)
- 360.3
- Beta (1Y)
- 1.15
- Revenue Growth
- 13.55%
- EPS Growth
- -77.69%
- Country
- India
- Employees
- 735
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Oriental Aromatics Ltd. Business Overview & Revenue Model
Company Description
Oriental Aromatics Limited, established in Mumbai, India, in 1955, is a leading manufacturer and supplier of terpene chemicals, camphor, and various specialty aroma ingredients. Operating as Camphor & Allied Products Limited until its rebranding in F...
How the Company Makes Money
OAL makes money primarily by manufacturing and selling aroma and specialty chemical products to business customers (B2B). Its core revenue stream is product sales: customers (such as fragrance houses, flavor and fragrance ingredient blenders, and for...
Oriental Aromatics Ltd. Financial Statement Overview
Summary
Revenue is rising, but profitability has deteriorated sharply: gross margin compressed materially and net margin is now extremely thin (≈0.3% in 2026). Cash generation is the major concern with operating cash flow and free cash flow negative in most years and worsening in 2026, while leverage has increased meaningfully—together signaling elevated funding and execution risk.
Income Statement
38NegativeBalance Sheet
62PositiveCash Flow
22Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.65B | 10.31B | 9.23B | 8.36B | 8.49B | 8.66B |
| Gross Profit | 1.03B | 1.02B | 1.30B | 1.52B | 1.62B | 1.89B |
| EBITDA | 727.41M | 775.92M | 966.65M | 534.64M | 543.09M | 969.36M |
| Net Income | 53.20M | 33.10M | 343.28M | 91.04M | 197.43M | 533.02M |
Balance Sheet | ||||||
| Total Assets | 0 | 11.94B | 11.45B | 9.95B | 9.86B | 8.65B |
| Cash, Cash Equivalents and Short-Term Investments | 131.28M | 146.14M | 111.85M | 111.76M | 181.12M | 77.28M |
| Total Debt | 0 | 4.03B | 3.53B | 2.06B | 2.31B | 1.40B |
| Total Liabilities | -6.65B | 5.30B | 4.82B | 3.63B | 3.62B | 2.60B |
| Stockholders Equity | 6.65B | 6.65B | 6.63B | 6.32B | 6.25B | 6.05B |
Cash Flow | ||||||
| Free Cash Flow | -342.96M | -441.80M | -1.45B | 424.36M | -689.99M | -603.09M |
| Operating Cash Flow | -304.21M | -323.99M | -578.94M | 1.42B | -223.00M | -8.14M |
| Investing Cash Flow | -38.75M | -116.43M | -865.04M | -989.66M | -464.66M | -594.42M |
| Financing Cash Flow | 258.42M | 465.75M | 1.44B | -482.00M | 781.48M | 514.81M |
Oriental Aromatics Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:OAL, the sentiment is Positive. The current price of 573.20 is above the 20-day moving average (MA) of 566.14, above the 50-day MA of 516.34, and above the 200-day MA of 357.90, indicating a bullish trend. The MACD of 27.08 indicates Positive momentum. The RSI at 52.43 is Neutral, neither overbought nor oversold. The STOCH value of 59.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:OAL.
Oriental Aromatics Ltd. Peers Comparison
Overall Rating
IN:FINEORG74.75Outperform
IN:GALAXYSURF59Neutral
IN:BALAMINES57.5Neutral
IN:OAL51Neutral
IN:LXCHEM50Neutral
IN:CAMLINFINE30Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 75Outperform | INR 154.84B | 35.84 | ― | 0.22% | 7.26% | 5.73% | |
| 59Neutral | INR 75.16B | 21.20 | ― | 1.04% | 27.05% | 16.13% | |
| 58Neutral | INR 57.16B | 27.90 | ― | 0.63% | 11.08% | 34.10% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 51Neutral | INR 19.29B | 360.32 | ― | 0.09% | 13.55% | -77.69% | |
| 50Neutral | INR 42.47B | 33.72 | ― | 0.20% | 5.47% | 24.88% | |
| 30Underperform | INR 16.15B | 323.46 | ― | ― | 8.40% | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:OAL | Oriental Aromatics Ltd. | 573.20 | 226.95 | 65.55% | |
| IN:BALAMINES | Balaji Amines Limited | 1764.15 | 351.10 | 24.85% | |
| IN:CAMLINFINE | Camlin Fine Sciences Limited | 84.05 | -115.70 | -57.92% | |
| IN:FINEORG | Fine Organic Industries Ltd. | 5050.20 | 641.21 | 14.54% | |
| IN:GALAXYSURF | Galaxy Surfactants Ltd. | 2119.80 | -117.93 | -5.27% | |
| IN:LXCHEM | Laxmi Organic Industries Ltd. | 152.80 | -43.86 | -22.30% |
Oriental Aromatics Ltd. Corporate Events
Oriental Aromatics Publishes AGM Notice in Line with SEBI Norms
Oriental Aromatics Limited notified stock exchanges that it has published newspaper advertisements regarding its 54th Annual General Meeting in leading English and Marathi dailies. The disclosure was made in line with SEBI Listing Regulations, unders...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 17, 2026